Threat Of Sudden Cardiac Arrest And Stroke Spotted By The Endotect™

Did you ever imagine that heart disease and stroke, two major causes of death, could be detected far in advance of occurrence? There are only a few medical diagnostic tools available that might indicate, broadly, your risks for these diseases. But no medical test is so specific, so easy and inexpensive to use, that can return results in less than 15 minutes on very early warning signs of cardio-vascular disease (CVD)... as the Endotect™.

Perhaps you have heard of people who just passed their annual physicals with flying colors, when soon after, they suddenly died of a heart attack. This has occurred, notably, even in young atheletes, supposedly in perfect health and condition. The surprise comes because the major cause of CVD is not detectable without intensive and expensive ultrasound tests, tests which are not customarily ordered by physicians without other signs of CVD appearing clinically.

Endotect, recently released by Israeli medical tech company Cardiatec, looks as nonthreatening as a blood pressure cuff... and it is. Endotect tests endothelial function, the function that ultimately determines whether you live or die as a result of a cardio-vascular incident, such as sudden cardiac arrest or stroke.

The endothelial cells compose the inner lining of all your blood vessels and arteries. They function to control blood pressure, blood clotting and the formation of new blood vessels, as well as other major physiological functions in the bloodstream. When these cells fail to function in their multitude of roles, the result is endothelial dysfunction (ED), that is the single identifiable factor in all CVD.

The Endotect tests epithelial function by measuring two physiological aspects of blood flow, pulse transit time and pulse pressure amplitude, taken at the arm arteries. Cardiatec has developed an algorithm to analyze the data from the Endotect results that provides the best measurement yet of endothelial functioning.

With the Endotect, diagnosis of ED can take place annually, as part of a routine physical. And, the best news is that ED, no matter what stage it's in, can be treated.

Endotect is expected to be approved by the FDA this year and to be marketed to the medical community in the U.S. by 2009. In the meantine, Cardiatec suggests that there are some natural ways to assist healthy endothelial function, including:

  • Flavonoid compounds that have high antioxidant properties and also improve endothelial function. Some known examples are, dark chocolate, red wine, green and red and black tea and purple grape juice.

  • CoQ10 for the general population and Vitamin C for smokers (both strong anti-oxidants).

  • Niacin elevates the good cholesterol (HDL) level. About 4 companies are now carrying out studies to develop drugs that will improve its efficacy.

  • L-arginine

  • Magnesium

via Israel 21C ; source: Cardiotec

Keeping you posted!





Jun 28, 2008
by Anonymous

Sudden Cardiac Death

I read an article in Health Journal, June 24th, about Vicor's PD2i Cardiac Analyzer. It uses an algorithm that can assess a patient's risk risk to die from Sudden Cardiac Death (SCD) by analyzing heart beats. The PD2i has the ability of predicting SCD, with greater than 95% sensitivity and 81% specificity within a six month period. The test can be administered in a cardiologist's office in 20 minutes. This device could save a number of lives.